Search Results | Cancer Research | American Association for Cancer Research

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Abstract 1653: Toward developing a humanized mouse model of the microenvironment associated with the malignant cells of Hodgkin lymphoma

Maria Teresa Bilotta, Antonella Antignani, David J. Fitzgerald

Cancer Res (2022) 82 (12_Supplement): 1653.

DOI: https://doi.org/10.1158/1538-7445.AM2022-1653

Published: 15 June 2022

View article

Journal Articles

Abstract 1739: Cell-specific cargo delivery using synthetic bacterial spores

Domenico D'Atri, Minsuk Kong, Maria Teresa Bilotta, Kandice Tanner, David J. Fitzgerald, Kumaran S. Ramamurthi

Cancer Res (2022) 82 (12_Supplement): 1739.

DOI: https://doi.org/10.1158/1538-7445.AM2022-1739

Published: 15 June 2022

View article

Journal Articles

Anticancer Effects of Mesothelin-Targeted Immunotoxin Therapy Are Regulated by Tyrosine Kinase DDR1

Fatima Ali-Rahmani, David J. FitzGerald, Scott Martin, Paresma Patel, Marco Prunotto, Pinar Ormanoglu, Craig Thomas, Ira Pastan

Cancer Res (2016) 76 (6): 1560–1568.

DOI: https://doi.org/10.1158/0008-5472.CAN-15-2401

Published: 14 March 2016

View article

Includes: Supplementary data

Journal Articles

Abstract 2907: Everolimus enhances the cytotoxic action of the immunotoxin, HA22, directed to CD22 on B-cell malignancies

Antonella Antignani, Matteo Pasetto, Chris Choo, Evan Angelus, Lesley Mathews, Rajarshi Guha, Paul Shinn, Marc Ferrer, Craig J. Thomas, Ira Pastan, David J. Fitzgerald

Cancer Res (2014) 74 (19_Supplement): 2907.

DOI: https://doi.org/10.1158/1538-7445.AM2014-2907

Published: 01 October 2014

View article

Journal Articles

Abstract 5482: Combining the anti-mesothelin immunotoxin SS1P with the BH3-mimetic ABT-737 induces cell death in SS1P-resistant pancreatic cancer cell lines.

Kevin Hollevoet, Antonella Antignani, David J. Fitzgerald, Ira Pastan

Cancer Res (2013) 73 (8_Supplement): 5482.

DOI: https://doi.org/10.1158/1538-7445.AM2013-5482

Published: 15 April 2013

View article

Journal Articles

The Insulin Receptor Negatively Regulates the Action of Pseudomonas Toxin-Based Immunotoxins and Native Pseudomonas Toxin

Xiu Fen Liu, David J. FitzGerald, Ira Pastan

Cancer Res (2013) 73 (7): 2281–2288.

DOI: https://doi.org/10.1158/0008-5472.CAN-12-3436

Published: 02 April 2013

View article

Includes: Supplementary data

Journal Articles

Treatment of Hematologic Malignancies with Immunotoxins and Antibody-Drug Conjugates

David J. FitzGerald, Alan S. Wayne, Robert J. Kreitman, Ira Pastan

Cancer Res (2011) 71 (20): 6300–6309.

DOI: https://doi.org/10.1158/0008-5472.CAN-11-1374

Published: 12 October 2011

View article

Journal Articles

Differential Cellular Internalization of Anti-CD19 and -CD22 Immunotoxins Results in Different Cytotoxic Activity

Xing Du, Richard Beers, David J. FitzGerald, Ira Pastan

Cancer Res (2008) 68 (15): 6300–6305.

DOI: https://doi.org/10.1158/0008-5472.CAN-08-0461

Published: 01 August 2008

View article

Includes: Supplementary data

Journal Articles

Polyethylene Glycol-modified Chimeric Toxin Composed of Transforming Growth Factor α and Pseudomonas Exotoxin

Qing-cheng Wang, Lee H. Pai, Waldemar Debinski, David J. FitzGerald, Ira Pastan

Cancer Res (1993) 53 (19): 4588–4594.

Published: 01 October 1993

View article

Journal Articles

Immunotoxins Made with a Recombinant Form of Pseudomonas Exotoxin A That Do Not Require Proteolysis for Activity

Charles P. Theuer, Robert J. Kreitman, David J. FitzGerald, Ira Pastan

Cancer Res (1993) 53 (2): 340–347.

Published: 01 January 1993

View article

Journal Articles

Antitumor Effects of B3-PE and B3-LysPE40 in a Nude Mouse Model of Human Breast Cancer and the Evaluation of B3-PE Toxicity in Monkeys

Lee H. Pai, Janendra K. Batra, David J. FitzGerald, Mark C. Willingham, Ira Pastan

Cancer Res (1992) 52 (11): 3189–3193.

Published: 01 June 1992

View article

Journal Articles

Antitumor Effects of Interleukin 6-Pseudomonas Exotoxin Chimeric Molecules against the Human Hepatocellular Carcinoma, PLC/PRF/5 in Mice

Clay B. Siegall, Robert J. Kreitman, David J. FitzGerald, Ira Pastan

Cancer Res (1991) 51 (11): 2831–2836.

Published: 01 June 1991

View article

Journal Articles

Antitumor Activity of a Transforming Growth Factor α-Pseudomonas Exotoxin Fusion Protein (TGF-α-PE40)

Lee H. Pai, Maria G. Gallo, David J. FitzGerald, Ira Pastan

Cancer Res (1991) 51 (11): 2808–2812.

Published: 01 June 1991

View article

Journal Articles

Cytotoxic Activity of a Recombinant Fusion Protein between Insulin-like Growth Factor I and Pseudomonas Exotoxin

Trevor I. Prior, Lee J. Helman, David J. FitzGerald, Ira Pastan

Cancer Res (1991) 51 (1): 174–180.

Published: 01 January 1991

View article

Journal Articles

Inhibition of Antibody Response to Pseudomonas Exotoxin and an Immunotoxin Containing Pseudomonas Exotoxin by 15-Deoxyspergualin in Mice

Lee H. Pai, David J. FitzGerald, Mark Tepper, Bernice Schacter, George Spitalny, Ira Pastan

Cancer Res (1990) 50 (24): 7750–7753.

Published: 01 December 1990

View article

Journal Articles

Expression of the Interleukin 6 Receptor and Interleukin 6 in Prostate Carcinoma Cells

Clay B. Siegall, Gisela Schwab, Richard P. Nordan, David J. FitzGerald, Ira Pastan

Cancer Res (1990) 50 (24): 7786–7788.

Published: 01 December 1990

View article

Journal Articles

Antitumor Activity of an Immunotoxin in a Nude Mouse Model of Human Ovarian Cancer

David J. FitzGerald, Michael J. Bjorn, Robert J. Ferris, Jeff L. Winkelhake, Arthur E. Frankel, Thomas C. Hamilton, Robert F. Ozols, Mark C. Willingham, Ira Pastan

Cancer Res (1987) 47 (5): 1407–1410.

Published: 01 March 1987

View article

NARROW

Abstract 1653: Toward developing a humanized mouse model of the microenvironment associated with the malignant cells of Hodgkin lymphoma

Abstract 1739: Cell-specific cargo delivery using synthetic bacterial spores

Anticancer Effects of Mesothelin-Targeted Immunotoxin Therapy Are Regulated by Tyrosine Kinase DDR1

Abstract 2907: Everolimus enhances the cytotoxic action of the immunotoxin, HA22, directed to CD22 on B-cell malignancies

Abstract 5482: Combining the anti-mesothelin immunotoxin SS1P with the BH3-mimetic ABT-737 induces cell death in SS1P-resistant pancreatic cancer cell lines.

The Insulin Receptor Negatively Regulates the Action of Pseudomonas Toxin-Based Immunotoxins and Native Pseudomonas Toxin

Treatment of Hematologic Malignancies with Immunotoxins and Antibody-Drug Conjugates

Differential Cellular Internalization of Anti-CD19 and -CD22 Immunotoxins Results in Different Cytotoxic Activity

Polyethylene Glycol-modified Chimeric Toxin Composed of Transforming Growth Factor α and Pseudomonas Exotoxin

Immunotoxins Made with a Recombinant Form of Pseudomonas Exotoxin A That Do Not Require Proteolysis for Activity

Antitumor Effects of B3-PE and B3-LysPE40 in a Nude Mouse Model of Human Breast Cancer and the Evaluation of B3-PE Toxicity in Monkeys

Antitumor Effects of Interleukin 6-Pseudomonas Exotoxin Chimeric Molecules against the Human Hepatocellular Carcinoma, PLC/PRF/5 in Mice

Antitumor Activity of a Transforming Growth Factor α-Pseudomonas Exotoxin Fusion Protein (TGF-α-PE40)

Cytotoxic Activity of a Recombinant Fusion Protein between Insulin-like Growth Factor I and Pseudomonas Exotoxin

Inhibition of Antibody Response to Pseudomonas Exotoxin and an Immunotoxin Containing Pseudomonas Exotoxin by 15-Deoxyspergualin in Mice

Expression of the Interleukin 6 Receptor and Interleukin 6 in Prostate Carcinoma Cells

Antitumor Activity of an Immunotoxin in a Nude Mouse Model of Human Ovarian Cancer

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only